根据诊断分类的首次全膝关节翻修术后的患者相关结局:利用国家关节登记数据集对植入物生存率、死亡率、严重内科并发症及患者报告结局指标的分析
本研究基于英国国家关节登记等数据库,分析2009年1月1日至2019年6月30日间24,540例首次全膝关节翻修术(rTKA),按不同指征评估植入物生存率、90天死亡率与严重内科并发症及6个月患者报告结局。结果显示不同指征间患者相关结局差异大,骨折或感染翻修者并发症最高,僵硬或不明原因疼痛翻修者关节功能最差。
要点
- 术后2年再翻修累积发生率从进展性关节炎的2.7%至感染的16.3%不等。
- 90天死亡率以骨折翻修(3.6%)和感染翻修(1.8%)最高,其他指征<0.5%。
- 僵硬或不明原因疼痛翻修者牛津膝关节评分均值仅24和25分,应答者比例最低(48%和55%)。
核心结论
- 首次rTKA不同指征间患者相关结局存在巨大差异,骨折或感染翻修者并发症率最高,僵硬和不明原因疼痛翻修者结局较差。
研究设计与样本
- 基于英国国家关节登记、医院 Episode 统计住院患者护理、国家卫生服务患者报告结局指标和死亡民事登记的人群队列研究,纳入2009年1月1日至2019年6月30日间首次rTKA患者。
主要发现
- 共分析24,540例首次rTKA,患者54%为女性、62%为白人,首次rTKA平均年龄69岁。
- 术后2年再翻修累积发生率从进展性关节炎的2.7%(95%CI 1.9%至3.4%)至感染的16.3%(95%CI 15.2%至17.4%)。
- 90天死亡率以骨折翻修3.6%(95%CI 2.5%至5.1%)和感染翻修1.8%(95%CI 1.5%至2.2%)最高,其他指征<0.5%。
- 90天内需住院的严重内科并发症率以骨折翻修21.8%(95%CI 17.9%至26.3%)和感染翻修12.5%(95%CI 11.2%至13.9%)最高,进展性关节炎翻修最低4.3%(95%CI 3.3%至5.5%)。
- 僵硬或不明原因疼痛翻修者术后关节功能最差,牛津膝关节评分均值分别为24分和25分,应答者比例最低分别为48%和55%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to investigate patient-relevant outcomes following first revision total knee arthroplasties (rTKAs) performed for different indications. METHODS: This population-based cohort study utilized data from the United Kingdom National Joint Registry, Hospital Episode Statistics Admitted Patient Care, National Health Service Patient-Reported Outcome Measures, and the Civil Registrations of Death. Patients undergoing a first rTKA between January 1, 2009, and June 30, 2019, were included in our data set. Patient-relevant outcomes included implant survivorship (up to 11 years postoperatively), mortality and serious medical complications (up to 90 days postoperatively), and patient-reported outcome measures (at 6 months postoperatively). RESULTS: A total of 24,540 first rTKAs were analyzed. The patient population was 54% female and 62% White, with a mean age at the first rTKA of 69 years. At 2 years postoperatively, the cumulative incidence of re-revision surgery ranged from 2.7% (95% confidence interval [CI], 1.9% to 3.4%) following rTKA for progressive arthritis to 16.3% (95% CI, 15.2% to 17.4%) following rTKA for infection. The mortality rate at 90 days was highest following rTKA for fracture (3.6% [95% CI, 2.5% to 5.1%]) and for infection (1.8% [95% CI, 1.5% to 2.2%]) but was <0.5% for other indications. The rate of serious medical complications requiring hospital admission within 90 days was highest for patients treated for fracture (21.8% [95% CI, 17.9% to 26.3%]) or infection (12.5% [95% CI, 11.2% to 13.9%]) and was lowest for those treated for progressive arthritis (4.3% [95% CI, 3.3% to 5.5%]). Patients who underwent rTKA for stiffness or unexplained pain had some of the poorest postoperative joint function (mean Oxford Knee Score, 24 and 25 points, respectively) and had the lowest proportion of responders (48% and 55%, respectively). CONCLUSIONS: This study found large differences in patient-relevant outcomes among different indications for first rTKA. The rate of complications was highest following rTKA for fracture or infection. Although rTKA resulted in large improvements in joint function for most patients, those who underwent surgery for stiffness and unexplained pain had worse outcomes. LEVEL OF EVIDENCE: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
引用
- Sabah SA, Knight R, Alvand A, et al. Patient-Relevant Outcomes Following First Revision Total Knee Arthroplasty, by Diagnosis: An Analysis of Implant Survivorship, Mortality, Serious Medical Complications, and Patient-Reported Outcome Measures Utilizing the National Joint Registry Data Set. J Bone Joint Surg Am. 2023. PMID: 37607237. doi:10.2106/JBJS.23.00251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。